Partillion Bioscience Announces Early Access Program for Nanovial Multicell Assays to Enable the Study of Cell-to-Cell Interactions
“Our Nanovial Multicell Assays are a game-changer, opening up new [...]
International Consortium to Revolutionize Viral Vector Manufacturing | Reports VVector Bio
“This project represents a paradigm shift towards improving viral vector [...]
Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeutic
HT-KIT cancer therapeutic is an antisense oligonucleotide that targets the [...]
NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines
NEC Bio Therapeutics, a Mannheim based German company focused on [...]
Rejuvenate Biomed and SAS Tap AI to Develop Disease-agnostic Drug Repurposing Discovery Tools
“Our partnership with SAS amplifies the core strengths of both [...]
RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® Lien
Razi Ingber, RedHill Biopharma and Chief Financial Officer, said: “We [...]
Brainomix and Boehringer Ingelheim Launch Strategic Partnership in Fibrosing Lung Disease
This landmark project will focus on the opportunity for AI [...]
Addex Therapeutics to Present at the Thirteenth London International Cough Symposium (13th LICS)
Mikhail Kalinichev, Head of Translational Science, will present at the [...]
Medsenic, a Subsidiary of BioSenic SA, Extends Key Patent to the United States
Medsenic SAS, subsidiary of BioSenic SA, is exploring the therapeutic [...]
Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ ®
IXCHIQ ® is the world’s only licensed chikungunya vaccine available [...]